Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05372614 |
| Title | Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Northwestern University | Recruiting | Chicago | Illinois | 60611 | United States | Details |
| Dana-Farber Cancer Institute | Recruiting | Boston | Massachusetts | 02215 | United States | Details |
| Washington University School of Medicine | Recruiting | Saint Louis | Missouri | 63110 | United States | Details |
| University of Pittsburgh Cancer Institute (UPCI) | Recruiting | Pittsburgh | Pennsylvania | 15232 | United States | Details |
| M D Anderson Cancer Center | Recruiting | Houston | Texas | 77030 | United States | Details |
| University of Wisconsin Carbone Cancer Center | Recruiting | Madison | Wisconsin | 53792 | United States | Details |